Stay updated on PROMO: Pembrolizumab in Osteosarcoma Clinical Trial
Sign up to get notified when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.

Latest updates to the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPublication sourcing text updated to clarify that entries in Publications are auto-filled from PubMed and may not all pertain to the study. The revision tag on the page updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the site-wide government funding/status notice from the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedThe two screenshots show only minor UI adjustments to the study page; core content such as the study design, eligibility criteria, outcomes, and enrollment appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange Detected- Added a government funding notice impacting information currency and operations, plus a resource link for Bone osteosarcoma, and updated revision to v3.2.0. - Removed the previous revision v3.1.0.SummaryDifference4%

- Check70 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.SummaryDifference0.1%

- Check84 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to PROMO: Pembrolizumab in Osteosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.